 4. HIV-1 plasma RNA 50 copiesml for at least 2 years with at least one measurement per year and most recent viral load within 16 weeks of enrollment and study drug initiation. Episodes of a single HIV plasma RNA 50 - 500 copiesml will not exclude participation if the subsequent HIV plasma RNA was 50 copiesml. 